Quadrant Capital Group’s Merck MRK Stock Holding History

Quadrant Capital Group’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.7M	Buy	88,834 +1,189	+1%	+$137K	0.32%	38
2025 Q4	$9.23M	Buy	87,645 +991	+1%	+$93K	0.28%	43
2025 Q3	$7.27M	Buy	86,654 +18,764	+28%	+$1.55M	0.24%	52
2025 Q2	$5.37M	Buy	67,890 +23,433	+53%	+$1.86M	0.19%	67
2025 Q1	$3.99M	Buy	44,457 +14,047	+46%	+$1.31M	0.15%	80
2024 Q4	$3.03M	Sell	30,410 -4,519	-13%	-$466K	0.21%	56
2024 Q3	$3.97M	Sell	34,929 -1,071	-3%	-$127K	0.28%	46
2024 Q2	$4.46M	Buy	36,000 +3,376	+10%	+$435K	0.33%	40
2024 Q1	$4.31M	Sell	32,624 -302	-0.9%	-$37.2K	0.34%	41
2023 Q4	$3.59M	Sell	32,926 -427	-1%	-$44.3K	0.31%	48
2023 Q3	$3.43M	Buy	33,353 +2,227	+7%	+$240K	0.34%	41
2023 Q2	$3.59M	Sell	31,126 -384	-1%	-$43.6K	0.36%	42
2023 Q1	$3.35M	Buy	31,510 +535	+2%	+$57.8K	0.35%	42
2022 Q4	$3.44M	Buy	30,975 +3,313	+12%	+$339K	0.39%	35
2022 Q3	$2.38M	Buy	27,662 +3,144	+13%	+$281K	0.32%	45
2022 Q2	$2.24M	Sell	24,518 -219	-0.9%	-$19.4K	0.3%	55
2022 Q1	$2.03M	Buy	24,737 +1,347	+6%	+$106K	0.25%	60
2021 Q4	$1.79M	Buy	23,390 +442	+2%	+$35.2K	0.21%	75
2021 Q3	$1.72M	Buy	22,948 +3,046	+15%	+$232K	0.24%	70
2021 Q2	$1.55M	Buy	19,902 +661	+3%	+$49.2K	0.22%	71
2021 Q1	$1.42M	Buy	19,241 +2,059	+12%	+$152K	0.23%	67
2020 Q4	$1.34M	Sell	17,182 -306	-2%	-$23.4K	0.25%	65
2020 Q3	$1.38M	Sell	17,488 -884	-5%	-$69.2K	0.3%	56
2020 Q2	$1.36M	Sell	18,372 -9,176	-33%	-$691K	0.3%	61
2020 Q1	$2.02M	Sell	27,548 -1,836	-6%	-$144K	0.34%	55
2019 Q4	$2.52M	Buy	29,384 +6,269	+27%	+$515K	0.3%	47
2019 Q3	$1.84M	Buy	23,115 +74	+0.3%	+$5.93K	0.28%	62
2019 Q2	$1.82M	Sell	23,041 -3,347	-13%	-$256K	0.29%	58
2019 Q1	$2.08M	Buy	26,388 +5,611	+27%	+$420K	0.36%	48
2018 Q4	$1.49M	Sell	20,777 -924	-4%	-$65.2K	0.4%	45
2018 Q3	$1.45M	Buy	21,701 +135	+0.6%	+$8.6K	0.41%	44
2018 Q2	$1.23M	Buy	21,566 +978	+5%	+$55.2K	0.43%	54
2018 Q1	$1.05M	Sell	20,588 -854	-4%	-$46.1K	0.38%	56
2017 Q4	$1.14M	Sell	21,442 -354	-2%	-$19.6K	0.45%	48
2017 Q3	$1.31M	Sell	21,796 -23	-0.1%	-$1.39K	0.54%	45
2017 Q2	$1.28M	Sell	21,819 -474	-2%	-$28.9K	0.57%	39
2017 Q1	$1.34M	Buy	22,293 +491	+2%	+$29.8K	0.59%	39
2016 Q4	$1.21M	Buy	21,802 +4,753	+28%	+$278K	0.61%	36
2016 Q3	$1M	Buy	17,049 +340	+2%	+$19.9K	0.65%	27
2016 Q2	$907K	Buy	16,709 +742	+5%	+$39.5K	0.62%	31
2016 Q1	$796K	Sell	15,967 -18	-0.1%	-$882	0.52%	33
2015 Q4	$797K	Buy	15,985 +1,002	+7%	+$50.5K	0.55%	32
2015 Q3	$700K	Sell	14,983 -131	-0.9%	-$6.96K	0.48%	38
2015 Q2	$815K	Buy	+15,114	New	+$848K	0.52%	34

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Quadrant Capital Group's MRK Position: Q1 2026 in Review

Quadrant Capital Group increased its Merck (MRK) stake by 1.4% in Q1 2026, buying an estimated $137K and bringing the position to 88,834 shares worth $10.7M. The position accounts for 0.32% of the portfolio, ranked #38.

Quadrant Capital Group first reported a position in MRK in Q2 2015 and has held it in 44 quarters since. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Quadrant Capital Group held 88,834 shares of Merck worth $10.7M as of Q1 2026.
Quadrant Capital Group bought 1,189 Merck shares in Q1 2026, an estimated $137K.
Merck made up 0.32% of Quadrant Capital Group's portfolio in Q1 2026, its #38 holding.
Quadrant Capital Group first reported a position in Merck in Q2 2015 and has held it in 44 quarters since.
3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.